NGM Biopharmaceuticals, Inc.
NGM · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$142 | -$163 | -$120 | -$102 |
| Dep. & Amort. | $2 | $4 | $6 | $7 |
| Deferred Tax | $5 | $0 | $4 | -$0 |
| Stock-Based Comp. | $29 | $32 | $26 | $16 |
| Change in WC | -$18 | -$21 | $4 | -$4 |
| Other Non-Cash | -$7 | $3 | $7 | $1 |
| Operating Cash Flow | -$132 | -$144 | -$73 | -$83 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$2 | -$2 | -$2 |
| Net Acquisitions | $0 | -$16 | $70 | $49 |
| Inv. Purchases | -$105 | -$273 | -$293 | -$178 |
| Inv. Sales/Matur. | $221 | $289 | $224 | $129 |
| Other Inv. Act. | $0 | $16 | -$70 | -$49 |
| Investing Cash Flow | $114 | $14 | -$72 | -$51 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2 | $3 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $54 | $150 | $36 |
| Financing Cash Flow | $2 | $54 | $150 | $36 |
| Forex Effect | $1 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15 | -$76 | $5 | -$99 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $73 | $153 | $149 | $247 |
| End Cash | $59 | $77 | $153 | $149 |
| Free Cash Flow | -$133 | -$146 | -$75 | -$85 |